Clinical Trial Update: Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing alirocumab to ezetimibe on top of statin in high cardiovascular risk patients with hypercholesterolemia in Asia has completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• alirocumab (alirocumab)

Snippet

Sponsor: Sanofi | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED | Results posted: 2019-09-30